跳至主要内容
临床试验/NCT01070017
NCT01070017已完成3 期

Community-based Accompaniment With Supervised Antiretrovirals in Lima, Peru

Brigham and Women's Hospital1 个研究点 分布在 1 个国家目标入组 1,244 人开始时间: 2010年2月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
1,244
试验地点
1
主要终点
Proportion with suppressed HIV viral load after starting HAART among those receiving community-based DOT-HAART versus the control group.

研究概览

简要总结

Using quantitative and qualitative data, this study will assess the impact of community accompaniment with supervised antiretrovirals (CASA) on HIV-positive individuals and community members in Lima, Peru.

详细描述

Community-based accompaniment with directly observed antiretroviral therapy (DOT-HAART) may improve adherence and clinical outcomes among impoverished individuals starting HAART in resource-poor settings. Furthermore, the utilization of community health workers may build social capital. This is cluster-randomized trial, with randomization at the level of health centers. Individuals in both intervention and control clusters will receive community-based adherence support (monthly adherence visits) and standard care. In addition, individuals residing in intervention clusters will receive 12 months of community-based DOT-HAART. We will enroll patients as well as community members (health providers, treatment supporters, and community health workers) to assess individual and community-level outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •for Patient Cohort:
  • •Age greater than or equal to 18;
  • •Diagnosis if HIV and meeting criteria for HAART;
  • •Lives in poverty;
  • •EITHER: 1) HAART naïve or 2) starting salvage therapy due to virologic failure;
  • •Documentation of baseline CD4 cell count and HIV load;
  • •Residence and receipt of HIV healthcare within the study catchment area

排除标准

  • •for Patient Cohort:
  • •Imprisoned or cannot give informed consent.
  • •Inclusion Criteria for Community Cohort:
  • •Working in a health establishments in study region;
  • •If health personnel, contracted employee caring for people living with HIV/AIDS.
  • •Exclusion Criteria for Community Cohort:
  • •Cannot give informed consent

研究组 & 干预措施

Intervention: DOT-HAART

Experimental

Intervention group will receive community-based monthly adherence visits, standard care, and DOT-HAART.

干预措施: DOT-HAART (Other)

No DOT-HAART

No Intervention

Control group receives community-based monthly adherence visits and standard care, but no DOT-HAART.

结局指标

主要结局

Proportion with suppressed HIV viral load after starting HAART among those receiving community-based DOT-HAART versus the control group.

时间窗: 18 and 24 months

次要结局

  • Identify mediating mechanisms of CASA effect on individual outcomes.(24 months)
  • Identify subgroups who respond best to CASA intervention.(24 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sonya Sunhi Shin

Dr.

Brigham and Women's Hospital

研究点 (1)

Loading locations...

相似试验